Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours-Reference-Cited by-同舟云学术

Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours

Published:2018-11-30 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Durgeau Aurélie^ORCID,Virk Yasemin,Gros Gwendoline,Voilin Elodie,Corgnac Stéphanie^ORCID,Djenidi Fayçal,Salmon Jérôme,Adam Julien,de Montpréville Vincent^ORCID,Validire Pierre,Ferrone Soldano,Chouaib Salem,Eggermont Alexander,Soria Jean-Charles,Lemonnier François,Tartour Eric^ORCID,Chaput Nathalie,Besse Benjamin,Mami-Chouaib Fathia

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-07603-1.pdf

Reference73 articles.

1. Hinrichs, C. S. & Rosenberg, S. A. Exploiting the curative potential of adoptive T-cell therapy for cancer. Immunol. Rev. 257, 56–71 (2014).

2. Barrett, D. M., Grupp, S. A. & June, C. H. Chimeric antigen receptor- and TCR-modified T cells enter Main Street and Wall Street. J. Immunol. 195, 755–761 (2015).

3. Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711–723 (2010).

4. Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480–489 (2011).

5. Wolchok, J. D. et al. Nivolumab plus ipilimumab in advanced melanoma. N. Engl. J. Med. 369, 122–133 (2013).

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine for Targeted Therapy of Lung Cancer: Advances and Developments;Current Drug Targets;2024-06

2. Differences in F pocket impact on HLA I genetic associations with autoimmune diabetes;Frontiers in Immunology;2024-03-25

3. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers;Frontiers in Immunology;2024-01-22

4. Revolutionizing Lung Cancer Treatment: Recent Breakthroughs in Immunotherapy;Immunotherapy Against Lung Cancer;2024

5. Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab;Nature Cancer;2023-04-10